Search

Tetrapyrrolic porphyrazine macrocycles with externally appended 2-pyridyl rings were synthesized and characterized as to their spectroscopic, electrochemical, and photophysical properties. The investigated compounds are represented as [Py 8 PzH 2 ], the unmetalated octakis(2-pyridyl)porphyrazine, and the metal complexes [Py 8 PzM], where M is Mg II (H 2 O), Cu II , Zn II , or Co II . The spectroscopic properties and the electrochemical behavior of these compounds were examined in solution of polar (pyridine, dimethyl sulfoxide, and dimethylformamide) and nondonor solvents (CHCl 3 , CH 2 Cl 2 ), and the data were compared with those obtained from earlier studies on the related tetrapyrazinoporphyrazines, [Py 8 TPyzPzM], and the tetraquinoxalinoporphyrazines, [Py 8 QxPzM], also bearing externally 2-pyridyl rings, and characterized by a more extended central π-conjugated macrocyclic framework. The newly synthesized porphyrazines possess good solubility and are present in their monomeric form in all the examined solvents as shown by UV-visible spectra. The unmetalated species and metal derivatives undergo multiple one-electron reductions within the potential range of the nonaqueous examined solvents. The derivatives with nonredox active metal centers could accept four electrons on the conjugated macrocycle, while the Co II complex was characterized by a single one-electron oxidation and five reductions in DMSO. The photosensitizer activity for the generation of singlet oxygen was also examined for the Mg II (H 2 O) and Zn II complexes in DMF, with measured Φ Δ values being, respectively, 0.42 and 0.64, this latter value indicating the Zn II species as being a promising material for use as anticancer agent in photodynamic therapy.

The Hippo kinases MST1/2 and LATS1/2 inhibit the oncoproteins TAZ/YAP and regulate T cell function. Hippo kinases also cooperate with the ATR-Chk1 and ATM-Chk2 pathways, central orchestrators of the DNA damage response (DDR). We hypothesized that MST1/2 and LATS1/2 localization differently impacts the efficacy of neoadjuvant therapy (NAT) in breast cancer, being protective when expressed in the cytoplasm of tumor cells and in tumor-infiltrating lymphocytes, whereas representing molecular determinants of chemoresistance when present in the nucleus as a consequence of their cooperation with the DDR. Diagnostic biopsies from 57 HER2-positive and triple-negative breast cancer patients treated with NAT were immunostained for evaluating the expression of phosphorylated MST1/2 (pMST1/2) and LATS1/2 (pLATS1/2) in tumor-infiltrating lymphocytes (TILs) and in cancer cells. TAZ and Chk1 immunostaining was exploited for investigating subcellular compartment-dependent activity of Hippo kinases. Nuclear pMST1/2 (pMST1/2 nuc ) expression was significantly associated with nuclear expression of Chk1 (p = 0.046), whereas cytoplasmic pMST1/2 (pMST1/2 cyt ) expression was marginally associated with cytoplasmic TAZ staining (p = 0.053). Patients whose tumors expressed pMST1/2 nuc were at increased risk of residual disease after NAT (pCR ypT0/is ypN0: OR 4.91, 95%CI: 1.57-15.30; pCR ypT0 ypN0: OR 3.59, 95%CI 1.14-11.34). Conversely, exclusive cytoplasmic localization of pMST1/2 (pMST1/2 cyt )seemed to be a protective factor (pCR ypT0/is ypN0: OR 0.34, 95%CI: 0.11-1.00; pCR ypT0 ypN0: OR 0.31, 95%CI 0.10-0.93). The subcellular localization-dependent significance of pMST1/2 expression suggests their involvement in different molecular networks with opposite impact on NAT efficacy. Larger studies are warranted to confirm these novel findings.

The photosensitizing activity of two multiply charged porphyrazine derivatives, i.e. the Zn II species [(CH 3 ) 8 LZn] 8+ and the Zn II /Pt II heterobimetallic complex [(PtCl 2 )(CH 3 ) 6 LZn] 6+ (neutralized byI - ions; L=tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazinato dianion) has been examined in the water medium in the presence of SDS under experimental conditions in which the two species are present exclusively in their monomeric form. The determined quantum yield values (Φ Δ ) for both complexes, of interest in photodynamic therapy (PDT), are 2.3-2.5 higher than that of the aluminium compound PcAlS mix (Photosens®) used as the reference standard, an encouraging result for the application of the two cationic species as anticancer curative drugs in PDT. Investigation was also extended to explore the cellular effects on the melanoma C8161 and the oral squamous carcinoma CA-1 cell lines like viability, cellular uptake, cell death modality and cell cycle distribution experiments. The IC 50 values for the Zn II and Zn II /Pt II cations are consistently lower than those of the reference standard, thus the degree of efficiency as anticancer agents being in the order octacation≫hexacation>PcAlS mix . A large prevalence of apoptosis with respect to necrosis is observed for both charged complexes. Thus, all achieved information from photoactivity and in vitro tests in water solution further enhance perspectives for the application of the two Zn II cation [(CH 3 ) 8 LZn] 8+ and the related Zn II /Pt II analog [(PtCl 2 )(CH 3 ) 6 LZn] 6+ as potential bi-multimodal anticancer drugs., (Copyright © 2017 Elsevier B.V. All rights reserved.)

Background: Body mass index (BMI) is largely investigated as a prognostic and predictive factor in triple-negative breast cancer (TNBC). Overweight and obesity are linked to a variety of pathways regulating tumor-promoting functions, including the DNA damage response (DDR). The DDR physiologically safeguards genome integrity but, in a neoplastic background, it is aberrantly engaged and protects cancer cells from chemotherapy. We herein verified the role of BMI on a previously assessed association between DDR biomarkers and pathological complete response (pCR) in TNBC patients treated with neoadjuvant chemotherapy (NACT)., Methods: In this retrospective analysis 54 TNBC patients treated with NACT were included. The relationship between DDR biomarkers, namely phosphorylated H2A Histone Family Member X (γ-H2AX) and phosphorylated checkpoint kinase 1 (pChk1), and pCR was reconsidered in light of BMI data. The Pearson's Chi-squared test of independence (2-tailed) and the Fisher Exact test were employed to assess the relationship between clinical-molecular variables and pCR. Uni- and multivariate logistic regression models were used to identify variables impacting pCR. Internal validation was carried out., Results: We observed a significant association between elevated levels of the two DDR biomarkers and pCR in patients with BMI < 25 (p = 0.009 and p = 0.022 for γ-H2AX and pChk1, respectively), but not in their heavier counterpart. Results regarding γ-H2AX were confirmed in uni- and multivariate models and, again, for leaner patients only (γ-H2AX high vs γ-H2AX low : OR 10.83, 95% CI: 1.79-65.55, p = 0.009). The consistency of this finding was confirmed upon internal validation., Conclusions: The predictive significance of γ-H2AX varies according to BMI status. Indeed, elevated levels of γ-H2AX seemed associated with lower pCR rate only in leaner patients, whereas differences in pCR rate according to γ-H2AX levels were not appreciable in heavier patients. Larger investigations are warranted concerning the potential role of BMI as effect modifier of the relationship between DDR-related biomarkers and clinical outcomes in TNBC.

Male breast cancer (MBC) is a rare hormone-driven disease often associated with obesity. HMG-CoAR is the central enzyme of the mevalonate pathway, a molecular route deputed to produce cholesterol and steroid-based hormones. HMG-CoAR regulates the oncogenic Hippo transducers TAZ/YAP whose expression was previously associated with shorter survival in MBC. 225 MBC samples were immunostained for HMG-CoAR and 124 were considered eligible for exploring its relationship with hormone receptors (ER, PgR, AR), Hippo transducers and survival outcomes. HMG-CoAR was positively associated with the expression of hormone receptors (ER, PgR, AR) and Hippo transducers. Overall survival was longer in patients with HMG-CoAR-positive tumors compared with their negative counterparts (p = 0.031). Five- and 10-year survival outcomes were better in patients whose tumors expressed HMG-CoAR (p = 0.044 and p = 0.043). Uni- and multivariate analyses for 10-year survival suggested that HMG-CoAR expression is a protective factor (HR 0.50, 95% CI: 0.25-0.99, p = 0.048 and HR 0.53, 95% CI: 0.26-1.07, p = 0.078). Results were confirmed in a sensitivity analysis by excluding uncommon histotypes (multivariate Cox: HR 0.45, 95% CI: 0.21-0.97, p = 0.043). A positive relationship emerged between HMG-CoAR, hormone receptors and TAZ/YAP, suggesting a connection between the mevalonate pathway, the hormonal milieu and Hippo in MBC. Moreover, HMG-CoAR expression may be a favorable prognostic indicator.

Male breast cancer (MBC) is a rare disease and its biology is poorly understood. Deregulated Hippo pathway promotes oncogenic functions in female breast cancer. We herein investigated the expression of the Hippo transducers TAZ/YAP and their target CTGF in MBC. Tissue microarrays containing samples from 255 MBC patients were immunostained for TAZ, YAP and CTGF. One hundred and twenty-nine patients were considered eligible. The Pearson's Chi-squared test of independence was used to test the association between categorical variables. The correlation between TAZ, YAP and CTGF was assessed with the Pearson's correlation coefficient. The Kaplan-Meier method and the log-rank test were used for estimating and comparing survival curves. Cox proportional regression models were built to identify variables impacting overall survival. Statistical tests were two-sided. Tumors were considered to harbor active TAZ/YAP-driven gene transcription when they co-expressed TAZ, or YAP, and CTGF. Patients whose tumors had the TAZ/CTGF and YAP/CTGF phenotypes experienced shorter overall survival compared with their negative counterparts (log rank p = 0.036 for both). TAZ/CTGF and YAP/CTGF tumors were associated with decreased survival in patients with invasive ductal carcinomas, G3 tumors, hormone receptor-positive tumors, and tumors with elevated Ki-67. Multivariate analyses confirmed that the TAZ/CTGF and YAP/CTGF phenotypes are independent predictors of survival (HR 2.03, 95% CI: 1.06-3.90, p = 0.033; and HR 2.00, 95% CI: 1.04-3.84, p = 0.037 respectively). Comparable results were obtained when excluding uncommon histotypes (TAZ/CTGF: HR 2.34, 95% CI: 1.16-4.73, p = 0.018. YAP/CTGF. HR 2.36, 95% CI: 1.17-4.77, p = 0.017). Overall, the TAZ/YAP-driven oncogenic program may be active in MBC, conferring poorer survival., Competing Interests: The authors declare no conflicts of interest.

Background: The Hippo signaling acts as a tumor-suppressor pathway that negatively regulates TAZ and YAP. Increasing evidence supports the activation of TAZ and YAP in breast cancer. Moreover, the Hippo pathway is involved in the biology of non-neoplastic cells residing in the tumor microenvironment. On this basis, we herein assessed TAZ and YAP in triple-negative breast cancer and its surrounding microenvironemnt in order to investigate their impact on pathological complete response (pCR) and tumor recurrence., Methods: Sixty-one triple-negative breast cancer patients treated with neoadjuvant chemotherapy were retrospectively evaluated. TAZ and YAP were assessed by immunohistochemistry and classified as positive or negative according to the percentage of tumor-expressing cells, cellular localization, and staining intensity. TAZ and YAP expression was also evaluated in non-lymphocytic stromal cells, tumor-infiltrating lymphocytes (TILs) and endothelial cells. The Pearson's Chi-squared test of independence was used to test the association between TAZ/YAP and clinical-molecular factors. A multivariate logistic regression model was generated to identify variables impacting pCR. The Kaplan-Meier method and the log-rank test were used for estimating and comparing survival curves. Cox proportional regression models were built to evaluate the risk of recurrence for the variables considered. Internal validation was carried out with a re-sampling without replacement method., Results: We did not observe any impact on pCR rate when TAZ and YAP were addressed singularly. Conversely, the combined expression of YAP in tumor cells and non-lymphocytic stromal cells was an independent predictor of reduced pCR rate in the multivariate model (OR 7.13, 95% CI: 1.23-41.41, p = 0.029). Next, the combined expression of TAZ and YAP was associated with shorter disease-free survival (DFS) in multivariate analysis (HR 3.07, 95% CI: 1.24-7.61, p = 0.016). The robustness of these findings were internally validated., Conclusions: The combined expression of YAP in TNBC cells and in the surrounding stroma seems to be associated with a decreased likelihood to achieve pCR. Conversely, the combined expression of TAZ and YAP in tumor cells conferred poor survival outcomes.

Response of cancer cells to chemotherapy-induced DNA damage is regulated by the ATM-Chk2 and ATR-Chk1 pathways. We investigated the association between phosphorylated H2AX (γ-H2AX), a marker of DNA double-strand breaks that trigger the ATM-Chk2 cascade, and phosphorylated Chk1 (pChk1), with pathological complete response (pCR) in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy. γ-H2AX and pChk1 were retrospectively assessed by immunohistochemistry in a series of pretreatment biopsies related to 66 patients. In fifty-three tumors hormone receptor status was negative in both the diagnostic biopsies and residual cancers, whereas in 13 cases there was a slight hormone receptor expression that changed after chemotherapy. Internal validation was carried out. In the entire cohort elevated levels of γ-H2AX, but not pChk1, were associated with reduced pCR rate (p = 0.009). The association tested significant in both uni- and multivariate logistic regression models (OR 4.51, 95% CI: 1.39-14.66, p = 0.012, and OR 5.07, 95% CI: 1.28-20.09, p = 0.021, respectively). Internal validation supported the predictive value of the model. The predictive ability of γ-H2AX was further confirmed in the multivariate model after exclusion of tumors that underwent changes in hormone receptor status during chemotherapy (OR 7.07, 95% CI: 1.39-36.02, p = 0.018). Finally, in residual diseases a significant decrease of γ-H2AX levels was observed (p < 0.001). Overall, γ-H2AX showed ability to predict pCR in TNBC and deserves larger, prospective studies.

Background: The primary objectives of this study on carcinomas with equivocal HER2 expression were to assess the impact of distinct recommendations with regard to identifying patients eligible for anti-HER2 agents by fluorescence in situ hybridization (FISH) and to elucidate whether multiplex ligation-dependent probe amplification (MLPA) may be of support in assessing HER2 gene status., Methods: A cohort of 957 immunohistochemistry-evaluated HER2-equivocal cases was analyzed by dual-color FISH. The results were assessed according to U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) guidelines and American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP) 2007 and 2013 guidelines for dual- and single-signal in situ hybridization (ISH) assays. A subgroup of 112 cases was subjected to MLPA., Results: HER2 amplification varied from 15% (ASCO/CAP 2007 HER2/CEP17 ratio) to 29.5% (FDA/EMA HER2 copy number). According to the ASCO/CAP 2013 interpretation of the dual-signal HER2 assay, ISH-positive carcinomas accounted for 19.7%. In contrast with the ASCO/CAP 2007 ratio, this approach labeled as positive all 32 cases (3.34%) with a HER2/CEP17 ratio <2 and an average HER2 copy number ≥6.0 signals per cell. In contrast, only one case showing a HER2 copy number <4 but a ratio ≥2 was diagnosed as positive. MLPA data correlated poorly with FISH results because of the presence of heterogeneous HER2 amplification in 33.9% of all amplified carcinomas; however, MLPA ruled out HER2 amplification in 75% of ISH-evaluated HER2-equivocal carcinomas., Conclusion: The ASCO/CAP 2013 guidelines seem to improve the identification of HER2-positive carcinomas. Polymerase chain reaction-based methods such as MLPA can be of help, provided that heterogeneous amplification has been ruled out by ISH., (©AlphaMed Press.)

Two new Mg(II) porphyrazine macrocycles, the octakis(2-pyridyl)porphyrazinato-magnesium(II), [Py8PzMg(H2O)], and the tetrakis-[6,7-di(2-pyridyl)quinoxalino]porphyrazinato-magnesium(II), [Py8QxPzMg(H2O)], were prepared by Mg-template macrocyclization processes, and their general physicochemical properties were examined. The previously reported porphyrazine analog, the tetrakis-2,3-[5,6-di(2-pyridyl)-pyrazino]porphyrazinato-magnesium(II), [Py8PyzPzMg(H2O)], has been also considered in the present work. The UV-visible solution spectra in nonaqueous solvents of this triad of externally octapyridinated Mg(II) complexes exhibit the usual profile observed for phthalocyanine and porphyrazine macrocycles, with intense absorptions in the Soret (300-450 nm) and Q band (600-800 nm) regions. It is observed that the Q band maximum sensibly shifts toward the red with peak values at 635 → 658 → 759 nm along the series [Py8PzMg(H2O)], [Py8PyzPzMg(H2O)], and [Py8QxPzMg(H2O)], as the extension of the macrocycle π-system increases. TDDFT calculations of the electronic absorption spectra were performed for the related water-free model compounds [Py8PzMg], [Py8PyzPzMg], and [Py8QxPzMg] to provide an interpretation of the UV-visible spectral changes occurring upon introduction of the pyrazine and quinoxaline rings at the periphery of the Pz macrocycle. To discriminate the electronic effects of the fused exocyclic rings from those of the appended 2-pyridyl rings, the UV-visible spectra of [PzMg] and [PyzPzMg] were also theoretically investigated. The theoretical results prove to agree very well with the experimental data, providing an accurate description of the UV-visible spectra. The observed spectral changes are interpreted on the basis of the electronic structure changes occurring along the series.

Telomeres consist of DNA tandem repeats that recruit the multiprotein complex shelterin to build a chromatin structure that protects chromosome ends. Although cancer formation is linked to alterations in telomere homeostasis, there is little understanding of how shelterin function is limited in cancer cells. Using a small-scale screening approach, we identified miR-155 as a key regulator in breast cancer cell expression of the shelterin component TERF1 (TRF1). miR-155 targeted a conserved sequence motif in the 3'UTR of TRF1, resulting in its translational repression. miR-155 was upregulated commonly in breast cancer specimens, as associated with reduced TRF1 protein expression, metastasis-free survival, and relapse-free survival in estrogen receptor-positive cases. Modulating miR-155 expression in cells altered TRF1 levels and TRF1 abundance at telomeres. Compromising TRF1 expression by elevating miR-155 increased telomere fragility and altered the structure of metaphase chromosomes. In contrast, reducing miR-155 levels improved telomere function and genomic stability. These results implied that miR-155 upregulation antagonizes telomere integrity in breast cancer cells, increasing genomic instability linked to poor clinical outcome in estrogen receptor-positive disease. Our work argued that miRNA-dependent regulation of shelterin function has a clinically significant impact on telomere function, suggesting the existence of "telo-miRNAs" that have an impact on cancer and aging., (©2014 American Association for Cancer Research.)

KRAS mutations are the most common oncogenic event in colorectal cancer (CRC) progression and their occurrence is associated with lack of response to anti epidermal growth factor receptor (EGFR) targeted therapies. Using preclinical models and patients' samples we recently reported that the emergence of KRAS mutations but also KRAS amplification is associated with acquired resistance to the EGFR inhibitors cetuximab or panitumumab. We reasoned that KRAS amplification may also be responsible for primary resistance to these agents. Furthermore, while the prevalence of KRAS mutations has been well established in CRC, little is known about the frequency of KRAS amplification in large CRC series. We performed a screening of 1,039 CRC samples to assess the prevalence of KRAS amplification in this tumor type and further evaluated the role of this genetic alteration on the sensitivity to anti EGFR therapies. We detected KRAS amplification in 7/1,039 (0.67%) and 1/102 evaluable CRC specimens and cell lines, respectively. KRAS amplification was mutually exclusive with KRAS mutations. Tumors or cell lines harboring this genetic lesion are not responsive to anti-EGFR inhibitors. Although KRAS amplification is an infrequent event in CRC, it might be responsible for precluding response to anti-EGFR treatment in a small proportion of patients., (Copyright © 2013 UICC.)

Background: An External Quality Assessment (EQA) program was developed to investigate the state of the art of HER2 immunohistochemical determination in breast cancer (BC) in 16 Pathology Departments in the Lazio Region (Italy). This program was implemented through two specific steps to evaluate HER2 staining (step 1) and interpretation (step 2) reproducibility among participants., Methods: The management activities of this EQA program were assigned to the Coordinating Center (CC), the Revising Centers (RCs) and the Participating Centers (PCs). In step 1, 4 BC sections, selected by RCs, were stained by each PC using their own procedures. In step 2, each PC interpreted HER2 score in 10 BC sections stained by the CC. The concordance pattern was evaluated by using the kappa category-specific statistic and/or the weighted kappa statistic with the corresponding 95% Jackknife confidence interval., Results: In step 1, a substantial/almost perfect agreement was reached between the PCs for scores 0 and 3+ whereas a moderate and fair agreement was observed for scores 1+ and 2+, respectively.In step 2, a fully satisfactory agreement was observed for 6 out of the 16 PCs and a quite satisfactory agreement was obtained for the remaining 10 PCs., Conclusions: Our findings highlight that in the whole HER2 evaluation process the two intermediate categories, scores 1+ and 2+, are less reproducible than scores 0 and 3+. These findings are relevant in clinical practice where the choice of treatment is based on HER2 positivity, suggesting the need to share evaluation procedures within laboratories and implement educational programs.

Objective: Lapatinib, a dual HER2/EGFR tyrosine kinase inhibitor (TKI), associated to capecitabine represents the treatment of choice in HER2-positive metastatic breast cancer (BC) patients in progression after trastuzumab-based therapy. Though lapatinib-based therapy prolongs the time to progression, its efficacy is often limited by the development of drug resistance. It is aimed to evaluate novel biomarkers predictive of lapatinib response, we analyzed EGFR protein and gene status in a series of 50 metastatic HER2-positive BC patients., Methods: Lapatinib was given at 1250 mg/day continuously and capecitabine at 2000 mg/m(2)/day every 3 weeks. EGFR protein expression and gene copy number (GCN) were assessed by immunohistochemistry and FISH, respectively. Receiver operating curve (ROC) analysis identified the value of > 3.36 EGFR copies/nucleus as the cut-off point able to discriminate responders versus non-responders., Results: A statistical significant correlation between EGFR GCN value > 3.36 and response to lapatinib (p = 0.01) was found. Cox regression analysis further supported these findings evidencing that HER2 score 3+ and EGFR GCN increase are positive predictor factors of lapatinib response., Conclusions: Though further investigations are needed to confirm these findings, EGFR GCN could be a suitable screening to identify the subset of BC patients particularly responsive to the dual TKI lapatinib.

In a prospective multicenter phase II trial of radioembolization with yttrium-90 ((90)Y-RE) in chemorefractory liver-dominant metastatic colorectal cancer (mCRC), we showed that median survival was 12.6 months (95% CI 7.0-18.3) with 48% of 50 patients achieving disease control. In this extension retrospective study, we analyzed whether a panel of biomarkers, known to be associated to an adverse clinical outcome, underwent variations in CRC liver metastases pre and post (90)Y-RE.Of the 50 patients included in the study, 29 pre-(90)Y-RE therapy and 15 post-(90)Y-RE had liver biopsy specimens available. In these series we investigated survivin, p53, Bcl-2 and Ki-67 expression pre- and post-(90)Y-RE by immuhistochemistry (IHC). Our findings evidenced a decrease of survivin (77% vs 33%), p53 (93% vs 73%), Bcl-2 (37% vs 26%) expression as well as of Ki-67 proliferation index (62.5% vs 40%) on liver biopsies collected post-(90)Y-RE as compared to pre-(90)Y-RE. In the subset of 13 matched liver metastases we further confirmed the reduction of survivin (92.3% vs 53.8%; p = 0.06), p53 (100% vs 69.2%; p = 0.05) and Bcl-2 (69.2% vs 53.8%; p = 0.05) expression post-(90)Y-RE. This biomarker modulation was accompanied by morphological changes as steatohepatitis, hepatocyte necrosis, collagen deposition, proliferating and/or bile duct ectasia, focal sinusoidal dilatation and fibrosis.Although our analysis was conducted in a very limited number cases, these changes appear strictly related to the response to (90)Y-RE therapy and may deserve further investigation on a larger series of patients.

Phospholipase Cγ1 (PLCγ1) is highly expressed in several tumors. We have previously reported that both stable and inducible PLCγ1 down-regulation resulted in an almost complete inhibition of breast cancer-derived experimental lung metastasis formation. The aim of our study is to evaluate the association between the expression of PLCγ1 and of PLCγ1 phosphorylated at Tyr1253 (PLCγ1-pY1253) and at Tyr783 (PLCγ1-pY783) with the clinical outcome of patients with node negative, T1/T2 breast cancers. The study groups consisted of 292 (training set) and 122 (validation set) patients presenting with primary unilateral breast carcinoma (T1-T2), with no evidence of nodal involvement and distant metastases. PLCγ1, PLCγ1-pY1253 and PLCγ1-pY783 protein expression were assessed by immunohistochemistry on tissue microarrays and the results correlated with the clinical data using Kaplan-Meier curves and multivariate Cox regression analysis. Tumor cells while expressing variable proportions of cytoplasmic PLCγ1, express PLCγ1-pY1253 and PLCγ1-pY783 predominantly in the nucleus. High expression of PLCγ1, and of its activated forms, is associated with a worse clinical outcome in terms of incidence of distant metastases, and not of local relapse in T1-T2, N0 breast cancer patients undergone adjuvant chemotherapy. PLCγ1 over-expression appears to be a reliable predictive surrogate marker of development of metastases. Thus, targeting PLCγ1 pathways might represent a potential therapeutic approach for the prevention of metastatic disease in breast cancer., (Copyright © 2012 UICC.)

We investigated with spectroscopic techniques the noncovalent interaction of a bimetallic water-soluble (Zn(II)/Pt(II)) porphyrazine hexacation, [(PtCl(2))(CH(3))(6)LZn](6+), and its octacationic analogue [(CH(3))(8)LZn](8+), lacking the cis-platin-like functionality, with a 21-mer double strand (ds) 5'-d[GGG(TTAGGG)(3)]-3'/3'-d[CCC(AATCCC)(3)]-5', as model for B-DNA. Both hexacation and octacation tend to aggregate in water. The structure as well as the ground and excited-state electronic properties of the Zn(II)/Pt(II) hexacation [(PtCl(2))(CH(3))(6)LZn](6+) in water solution were investigated using density functional theory (DFT) and time-dependent DFT (TDDFT) methods. TDDFT calculations of the lowest excited states of [(PtCl(2))(CH(3))(6)LZn](6+) in water provided an accurate description of the Q-band spectral region. In particular, the calculated optical spectra were in agreement with the experimental ones, obtained in the presence of micelles favoring complete disruption of the aggregates. The model for dsDNA binding that emerges from the analysis of UV-vis absorption and time-resolved fluorescence data shows the presence of complexes of 1 dsDNA molecule with 1, 2, and 4 macrocycles. Comparing the results for the hexacation [(PtCl(2))(CH(3))(6)LZn](6+) with those for the [(CH(3))(8)LZn](8+)octacation, we observed a higher degree of monomerization for the [(PtCl(2))(CH(3))(6)LZn](6+) derivative.

Heteropentanuclear porphyrazines having the formula [(PtCl2)4LM] where L = tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazinato dianion and M = Zn(II), Mg(II)(H2O), Pd(II), Cu(II) or Co(II) were characterized by elemental analyses, IR-UV-visible spectroscopy and electrochemistry and the data compared to new and previously published results for the corresponding homopentanuclear compound [(PtCl2)4LPt]. This latter species has four external N2(py)PtCl2 coordination sites which closely resemble cis-platin, (NH3)2PtCl2, the potent chemotherapeutic anticancer drug, and is able to act as a photosensitizer for the generation of (1)O2, the cytotoxic agent in photodynamic therapy (PDT). UV-visible spectra and half wave potentials for reduction of [(PtCl2)4LM], [(PtCl2)4LPt], the parallel series of mononuclear [LM] compounds and the pentanuclear [(PdCl2)4LM] compounds were examined in the nonaqueous solvents dimethyl sulfoxide, pyridine, and dimethylformamide. The complete set of available data indicate that external coordination of the PtCl2 and PdCl2 units significantly increases the level of the electron-deficiency of the entire molecular framework despite the fact that these groups are far away from the central porphyrazine π-ring system and have coordination sites nearly orthogonal to the plane of the macrocycle. The pentanuclear species [(M'Cl2)4LM] (M' = Pt(II), Pd(II)) undergo multiple one-electron transfers and exhibit an easier reducibility as compared to related electrode reactions of the parent compounds [LM] having the same central metal. Aggregation phenomena and reducibility of the porphyrazines to their monoanionic form (prevalently in DMF) are observed for some of the examined compounds and were analyzed and accurately taken into account. Quantum yields of (1)O2 (ΦΔ), of interest in PDT, were measured for [(PtCl2)4LM] with M = Zn(II), Mg(II)(H2O), or Pd(II) and the related macrocycles [(PdCl2)4LM] and [LM] in dimethylformamide (DMF) and/or DMF preacidified with HCl (DMF/HCl, [HCl]: 1-2 × 10(-4) M). Excellent ΦΔ values (0.5-0.6) which qualify the compounds as potent photosensitizers in PDT were obtained for the pentanuclear species having Zn(II) or Pd(II) as central metal ions. The [(PtCl2)4LZn] and [(PtCl2)4LPd] complexes are of special interest as potential bimodal anticancer agents because of the incorporated four cis-platin-like functionalities.

The photoactivity for the generation of singlet oxygen, (1)O(2), the key cytotoxic agent in the anticancer treatment known as photodynamic therapy (PDT), and the fluorescence response of the highly electron-deficient tetrakis(thiadiazole)porphyrazines of formula [TTDPzM] (M = Mg(II)(H(2)O), Zn(II), Al(III)Cl, Ga(III)Cl, Cd(II), Cu(II), 2H(I)) were examined (c ≅ 10(-5) M) in dimethylformamide (DMF) and/or in DMF preacidified with HCl (DMF/HCl; [HCl] = 1-4 × 10(-4) M). The singlet oxygen quantum yield (Φ(Δ)) of all the compounds was determined by using a widely employed procedure based on the selective oxidation of the 1,3-diphenylisobenzofuran (DPBF), modified in part as reported. The list of the Φ(Δ) values indicates excellent photosensitizing properties for the series of compounds carrying "closed shell" metal ions, with values measured in DMF/HCl respectful of the "heavy atom effect" for the first four lighter centers, increasing in the order Mg(II) < Al(III) < Zn(II) < Ga(III). Data of Φ(Δ) concerning the unmetalated species [TTDPzH(2)], present in solution in the form of the corresponding anion [TTDPz](2-), and the Cd(II) and Cu(II) complexes are also presented and discussed. Extensive discussion is also developed on the fluorescence quantum yield values Φ(F), with data on the Mg(II) and Al(III) compounds in DMF/HCl (0.44 and 0.53, respectively) indicative of promising perspectives for applications in fluorescence imaging techniques. The Φ(F) data of the studied porphyrazine series, Φ(F)(Pz), correlate linearly with those of the homologous phthalocyaninato complexes, Φ(F)(Pc), suggesting a closely similar behaviour between the two classes of compounds. The incorporation of [TTDPzZn] into liposomes was successfully achieved following the detergent depletion method (DDM) from a mixed micellar solution by means of gel-filtration. Retention of [TTDPzZn] (~40%) in its photoactive monomeric form into liposomes is proved by absorption and fluorescence spectra, this proposing the Zn(II) complex as a promising candidate for use in PDT.

We report the synthesis, crystal structure, and magnetic, electrochemical, and carrier-transport properties of vanadyl tetrakis(thiadiazole)porphyrazine (abbreviated as VOTTDPz) with S = ½. X-ray crystal analysis reveals two polymorphs, the α and β forms; the former consists of a 1D regular π stacking, while the latter forms a 2D π network. Molecular orbital calculations suggest a V(4+)(d(1)) ground state and a characteristic spin polarization on the whole molecular skeleton. The temperature dependence of the paramagnetic susceptibility of the α form clearly indicates a ferromagnetic interaction with a positive Weiss constant of θ = 2.4 K, which is well-explained by McConnell's type I mechanism. VOTTDPz forms amorphous thin films with a flat and smooth surface, and their cyclic voltammogram curves indicate a one-electron reduction process, which is highly electrochromic, because of a reduction of the porphyrazine π ring. Thin-film field-effect transistors of VOTTDPz with ionic-liquid gate dielectrics exhibit n-type performance, with a high mobility of μ = 2.8 × 10(-2) cm(2) V(-1) s(-1) and an on/off ratio of 10(4), even though the thin films are amorphous.

The solid state and solution structure of 2,3-dicyano-5,6-di(2-thienyl)-1,4-pyrazine, [(CN)(2)Th(2)Pyz], and its Pd(II) derivative, [(CN)(2)Th(2)Pyz(PdCl(2))(2)]·H(2)O, formed by reaction of [(CN)(2)Th(2)Pyz] with [(C(6)H(5)CN)(2)PdCl(2)] were characterized by X-ray, UV-visible, (1)H and (13)C NMR, and extended X-ray absorption fine structure (EXAFS) spectral measurements. The X-ray crystal structure of [(CN)(2)Th(2)Pyz] shows the presence of one thienyl ring positioned orthogonal to the rest of the molecule, with the two vicinal thienyl rings lying orthogonal to each other in a rare arrangement. NMR studies of [(CN)(2)Th(2)Pyz] in the solid state and in solutions of dimethylformamide or dimethyl sulfoxide confirm a nonequivalence of the thienyl rings in the solid state and also in solution. EXAFS results indicate that two distinct Pd(II) coordination sites are formed at the di(2-thienyl)pyrazino moiety of [(CN)(2)Th(2)Pyz(PdCl(2))(2)]·H(2)O, with identical Pd-N(pyz) (2.03(3) Å) and Pd-Cl (2.36(3) Å) bond lengths but with different Pd-S1 (2.25(4) Å) and Pd-S2 (3.21(5) Å) bond distances in an overall asymmetric molecular framework. Density functional theory (DFT) and time-dependent DFT (TDDFT) theoretical studies also provide information about the structure and spectral behavior of the precursor and its metalated Pd(II) derivative. (1)H/(13)C NMR and UV-visible spectral measurements were also carried out on two heteropentametallic porphyrazine macrocycles which were prepared by a reaction of PdCl(2) with [Th(8)TPyzPzM] where Th(8)TPyzPz = tetrakis-2,3-[5,6-di-(2-thienyl)-pyrazino]porphyrazinato dianion and M = Mg(II)(H(2)O) or Zn(II). Spectroscopic data on the newly synthesized [(PdCl(2))(4)Th(8)TPyzPzM] compounds suggest that the binding of PdCl(2) involves coordination sites of the type S(2(th))PdCl(2) with the two thienyl rings of each di(2-thienyl)pyrazino fragment bound to Pd(II) in an equivalent manner ("th-th" coordination). This is similar to what was found for the corresponding octapyridinated analogues ("py-py" coordination).

Background: Human Leukocyte Antigen (HLA)-E is a non-classical class I HLA molecule that can be stabilized by ligands donated by other classical (HLA-A, -B, -C) and non-classical (HLA-G) family members. HLA-E engages a variety of immune receptors expressed by cytotoxic T lymphocytes (CTLs), Natural killer (NK) cells and NK-CTLs. In view of the opposing outcomes (activation or inhibition) of the different HLA-E receptors, the preferred role (if any) of HLA-E expressed in vivo on tumor cells remains to be established., Methods: Taking advantage of MEM-E/02, a recently characterized antibody to denatured HLA-E molecules, HLA-E expression was assessed by immunohistochemistry on an archival collection (formalin-fixed paraffin-embedded) of 149 colorectal primary carcinoma lesions paired with their morphologically normal mucosae. Lymphoid infiltrates were assessed for the expression of the HLA-E-specific, inhibitory, non-rearranging receptor NKG2A., Results: High HLA-E expression did not significantly correlate with the expression of classical HLA-B and HLA-C molecules, but it did correlate with high expression of its preferential ligand donor HLA-A. In addition, it correlated with lymphoid cell infiltrates expressing the inhibitory NKG2A receptor, and was an independent predictor of good prognosis, particularly in a subset of patients whose tumors express HLA-A levels resembling those of their paired normal counterparts (HLA-A). Thus, combination phenotypes (HLA-Elo-int/HLA-AE and HLA-Ehi/HLA-AE) of classical and non-classical class I HLA molecules mark two graded levels of good prognosis., Conclusions: These results suggest that HLA-E favors activating immune responses to colorectal carcinoma. They also provide evidence in humans that tumor cells entertain extensive negotiation with the immune system until a compromise between recognition and escape is reached. It is implied that this process occurs stepwise, as predicted by the widely accepted 'immunoediting' model.

A series of pyrazinoporphyrazine macrocycles carrying externally appended 2-thienyl rings, represented as [Th(8)TPyzPzM], where Th(8)TPyzPz = tetrakis-2,3-[5,6-di(2-thienyl)pyrazino]porphyrazinato anion and M = Mg(II)(H(2)O), Zn(II), Co(II), Cu(II), or 2H(1), were prepared and isolated as solid air-stable hydrated species. All of the compounds, completely insoluble in water, were characterized by their UV-visible spectra and electrochemical behavior in solutions of dimethylformamide (DMF), dimethyl sulfoxide, and pyridine. Molecular aggregation occurs at concentrations of ca. 10(-4) M, but monomers are formed in more dilute solutions of 10(-5) M or less. The examined octathienyl compounds [Th(8)TPyzPzM] behave as electron-deficient macrocycles, and UV-visible spectral measurements provide useful information about how the peripheral thienyl rings influence the electronic distribution over the entire macrocyclic framework. Cyclic voltammetric and spectroelectrochemical data confirm the easier reducibility of the compounds as compared to the related phthalocyanine analogues, and the overall redox behavior and thermodynamic potentials for the four stepwise one-electron reductions of the compounds are similar to those of the earlier examined octapyridinated analogues [Py(8)TPyzPzM]. Quantum yields (Φ(Δ)) for the generation of singlet oxygen, (1)O(2), the cytotoxic agent active in photodynamic therapy (PDT), and fluorescence quantum yields (Φ(F)) were measured for the Zn(II) and Mg(II) complexes, [Th(8)TPyzPzZn] and [Th(8)TPyzPzMg(H(2)O)], and the data were compared to those of corresponding octapyridino macrocycles [Py(8)TPyzPzZn] and [Py(8)TPyzPzMg(H(2)O)] and their related octacations [(2-Mepy)(8)TPyzPzZn](8+) and [(2-Mepy)(8)TPyzPzMg(H(2)O)](8+). These measurements were carried out in DMF and in DMF preacidified with HCl (ca. 10(-4) M). All of the examined Zn(II) compounds behave as excellent photosensitizers (Φ(Δ) = 0.4-0.6) both in DMF and DMF/HCl solutions, whereas noticeable fluorescence activity (Φ(F) = 0.36-0.43) in DMF/HCl solutions is shown by the Mg(II) derivatives; these data might provide perspectives for applications in PDT (Zn(II)) and imaging response and diagnosis (Mg(II)).

New homo- and heterobimetallic porphyrazine complexes of general formula [(M'Cl(2))LM] (L = tetrakis-2,3-[5,6-di-(2-pyridyl)pyrazino]porphyrazinato dianion), with M = Zn(II), Mg(II)(H(2)O), or Pd(II) in the central cavity and one M'Cl(2) unit (M' = Pd(II), Pt(II)) peripherally coordinated at the pyridine N atoms of one of the dipyridinopyrazine fragments, were prepared and characterized by elemental analyses and IR/UV-visible spectroscopy. Related water-soluble salt-like species, carrying the hexacations [(PtCl(2))(CH(3))(6)LM](6+) (neutralized by I(-) ions), were also prepared and similarly characterized. Retention of clathrated water molecules is a common feature of all the compounds. A detailed (1)H and (13)C NMR investigation in dimethylformamide (DMF-d(7)) and dimethyl sulfoxide (DMSO-d(6)) provided useful information on the type of arrangement in the neutral and hexacationic species of the metalated dipyridinopyrazine fragments, in which the metal centers (Pd(II)/Pt(II)) are bound to the pyridine N atoms ("py-py" coordination) with formation of N(2(pyr))PdCl(2) or N(2(pyr))PtCl(2) coordination sites, the latter one featuring a cis-platin-like functionality. Data obtained in DMF solution of the quantum yield (Φ(Δ)) for the generation of singlet oxygen, (1)O(2), the cytotoxic agent in photodynamic therapy (PDT), indicate that all the neutral and charged complexes, among them particularly those carrying centrally Zn(II) or Pd(II), exhibit excellent photosensitizing properties, this qualifying the externally platinated complexes as potential bimodal PDT/chemotherapeutic anticancer agents. Fluorescence data (Φ(F)) provided additional information on the photoactivity of all the species studied. The following companion paper describes the observed interaction of the Zn(II) hexacation [(PtCl(2))(CH(3))(6)LZn](6+) with a G-quadruplex (G4) structure of the telomeric DNA sequence 5'-d[AGGG(TTAGGG)(3)]-3' in water., (© 2011 American Chemical Society)

The behavior of a bimetallic water-soluble (Zn(II)/Pt(II)) porphyrazine hexacation as ligand of G-quadruplex (G4) structures adopted by a human telomeric DNA sequence has been examined with different spectroscopic techniques. In K(+) rich solution the hexacationic Zn(II) porphyrazine ligand bearing a peripheral cis-platin-like functionality changes the G-quadruplex conformational equilibrium of the human telomeric sequence 5'-d[AGGG(TTAGGG)(3)]-3' and drives it exclusively toward a very stable parallel G4 form in the complex with 2:1 stoichiometry. An increase of the melting temperature of more than 20 °C is observed in this complex compared to the G4 alone. On the contrary ligand binding to G-quadruplex of the same telomeric sequence in Na(+) rich solution neither markedly influences the predominant basket conformation nor confers increased thermal stability to the G4 structure., (© 2011 American Chemical Society)

Purpose: To analyze HER2 status in primary breast cancer (PBC) compared with correspondent metachronous metastases and to investigate whether BC phenotype may be predictive of change in HER2 expression., Experimental Design: HER2 was investigated by immunohistochemistry, silver in situ hybridization (SISH), and FISH, in a series of 137 tumors, building up a tissue microarray to concurrently analyze each single PBC and metastatic (MBC) on the same slide., Results: HER2 status was discordant in 14 cases (10%): 12 negative in PBC and positive in metastases and two positive in PBC and negative in metastases (P = 0.04). These findings were confirmed by a PCR based test termed Multiplex Ligation-dependent Probe Amplification (MLPA). HER2 status changed in hormone receptor-positive BC more frequently than in negative ones (P = 0.002). In addition, we evaluated HER2 gene and chromosome 17 copy number by SISH in the 123 cases with unchanged HER2 status during progression. We found consistent HER2 gene copy number stability in the 100 nonamplified cases. Conversely, of the 23 amplified PBC, 13 (57%) demonstrated a significant increase in the HER2 gene and chromosome 17 copy number in their paired metastases (P = 0.01), as defined by SISH (k = 0.54, P < 0.0001) and MLPA. Patients who changed HER2 status from negative to positive, presented significant longer time to progression when treated with trastuzumab compared to those who were untreated (P = 0.04)., Conclusions: When feasible, HER2 reassessment in metastatic lesions should be carefully taken into account, especially for metastases coming from primary hormone receptor-positive BC.

Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel therapies are in urgent demand. The polymerase of HCV is responsible for the replication of viral genome and has been a prime target for drug discovery efforts. Here, we report on the further development of tetracyclic indole inhibitors, binding to an allosteric site on the thumb domain. Structure-activity relationship (SAR) studies around an indolo-benzoxazocine scaffold led to the identification of compound 33 (MK-3281), an inhibitor with good potency in the HCV subgenomic replication assay and attractive molecular properties suitable for a clinical candidate. The compound caused a consistent decrease in viremia in vivo using the chimeric mouse model of HCV infection.

A series of heteropentametallic porphyrazine macrocycles, represented as [(PdCl(2))(4)LM], where L = dianion of tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazine and M = Zn(II), Cu(II) Mg(II)(H(2)O) or Cd(II), were prepared by reaction of the corresponding mononuclear [LM] species, and their behavior was examined by UV-visible and NMR spectroscopy, electrochemistry, and thin layer spectroelectrochemistry in nonaqueous media. The PdCl(2) units in [(PdCl(2))(4)LM] are coordinated at the pyridine N atoms of the external dipyridinopyrazine fragments ("py-py" coordination) and are displaced out of the plane of the central pyrazinoporphyrazine macrocycle as verified by (1)H and (13)C NMR data on [(PdCl(2))(4)LZn]. The same arrangement is also strongly suggested by similar NMR data on the Mg(II) and Cd(II) analogues. The predominant component in the synthesized materials among the four predictable macrocyclic isomers has the four exocyclic N(2(py))PdCl(2) square planar coordination sites on the same side of the central macrocyclic framework (4:0 isomer, C(4v) symmetry), and this is accompanied by a minor isomeric component (2:2 cis or trans), in line with previous findings on the pentapalladated species [(PdCl(2))(4)LPd]. IR, UV-visible, and NMR spectral data also provide evidence for transmetalation reactions of the type [(PdCl(2))(4)LMg(H(2)O)] --> [(PdCl(2))(4)LPd] and [(PdCl(2))(4)LCd] --> [(PdCl(2))(4)LPd], with the amount of [(PdCl(2))(4)LPd] formed varying from batch to batch. Dissociation of the four exocyclic PdCl(2) units from [(PdCl(2))(4)LM] occurs in pyridine, but the compounds are stable in N,N-dimethylformamide (DMF) or dimethylsulfoxide (DMSO) and can be stepwise reduced via two one-electron reversible or quasi-reversible processes, prior to an irreversible electroreduction of the bound PdCl(2) group at more negative potentials. This metal-centered reduction leads to a [LM](2-) product which is then further reduced to [LM](3-) and [LM](4-) at the electrode surface. The first two reductions of the heteropentametallic compounds are easier than those of the monometallic [LM] species but generally more difficult than reduction of the related octacationic [L'M](8+) derivatives (L' = the octamethylated free-base dianion) whose redox properties were previously reported. The Cd(II) octacation [L'Cd](8+), isolated as an iodide salt, was also synthesized for the first time in the current study, and its spectroscopic and electrochemical properties are compared to that of the previously examined analogues.

A series of 2-(3-thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acid inhibitors of the hepatitis C virus (HCV) NS5B polymerase enzyme are reported. Sulfonyl urea substituted analogs in this series proved to be the most potent active site non-nucleoside inhibitors of NS5B reported to date. These compounds had low nanomolar enzyme inhibition across HCV genotypes 1-3 and showed single digit micromolar inhibition in the HCV replicon assay. This improved cell-based activity allowed the binding mode of these compounds to be probed by selection of resistant mutations against compound 21. The results generated are in broad agreement with the previously proposed binding model for this compound class.

Following previous cyclic voltammetric studies of tetrakis(thiadiazole)porphyrazines [TTDPzM] where M = Zn(II), Mg(II)(H(2)O), Cu(II), or 2H(I) in nonaqueous media, a thin-layer spectroelectrochemical investigation was carried out in pyridine to characterize each stepwise one-electron reduction of the electrogenerated [TTDPzM](n-) complexes where n = 1-4. A similar UV-visible spectrum was observed for each form of the anion, independent of the central metal ion and detailed theoretical calculations by density functional theory (DFT) and time-dependent DFT (TDDFT) methods were applied to interpret the spectral features of [TTDPzZn](n-) (n = 1-4) which was selected as representative for describing the ground and excited-state electronic structures of the entire [TTDPzM](n-) series. The use of two exchange-correlation functionals, the pure, asymptotically correct statistical average of orbital potentials (SAOP) and the hybrid B3LYP functionals, proved to be essential for attaining a correct assignment of the key spectral features. The nature and intensity of the main spectral features are highlighted and interpreted on the basis of the ground-state electronic structure of the complexes.

2,3-Dicyano-5,6-di-2-pyridylpyrazine, [(CN)(2)Py(2)Pyz], which autocyclotetramerizes to give the macrocycle tetrakis[5,6-di(2-pyridyl)-2,3-pyrazino]porphyrazine, [Py(8)TPyzPzH(2)], bearing externally four dipyridinopyrazine fragments, reacts with bis(benzonitrile)dichloroplatinum(II), [(C(6)H(5)CN)(2)PtCl(2)], in CH(3)CN, affording the monometalated species [(CN)(2)Py(2)PyzPtCl(2)]. Single-crystal X-ray work on this compound shows that Pt(II) is bound to [(CN)(2)Py(2)Pyz] through the two pyridine N atoms ("py-py" coordination) in a way similar to that found for its monopalladium analogue, [(CN)(2)Py(2)PyzPdCl(2)]. Cyclic voltammetry of [(CN)(2)Py(2)PyzPtCl(2)] and [(CN)(2)Py(2)PyzPdCl(2)] in nonaqueous media (pyridine, DMSO, and DMF) indicates that the electron-withdrawing effect of the coordinated PtCl(2) and PdCl(2) units results in an initial one-electron reduction (E(1/2) = -0.60 and -0.54 V vs SCE in DMSO, respectively), which is easier by 0.25-0.30 V than the unmetalated [(CN)(2)Py(2)Pyz] (first reduction: E(1/2) = -0.87 V vs SCE). These electrochemical data are analyzed along with new results for a selected number of related pyrazine and 2,3-dicyanopyrazine molecules as well as earlier reported data on the mono- and bis-N-methylated derivatives [(CN)(2)Py(2-Mepy)Pyz](+) and [(CN)(2)(2-Mepy)(2)Pyz](2+), with these latter species being formed by reaction of the precursor [(CN)(2)Py(2)Pyz] with methyl iodide or p-toluensulfonate. The data in this study are also compared to electrochemical data previously reported for a triad of palladium(II) porphyrazine macrocycles obtained from the precursor [(CN)(2)Py(2)Pyz], i.e., [Py(8)TPyzPzPd], the corresponding pentanuclear complex [(PdCl(2))(4)Py(8)TPyzPzPd] (presenting "py-py" coordination at the dipyridinopyrazine fragments), and the octacation [(2-Mepy)(8)TPyzPzPd](8+) (N-methylated at the pyridine rings). Thin-layer UV-visible spectra of singly reduced [(CN)(2)Py(2)Pyz](-) and its metalated analogues, [(CN)(2)Py(2)PyzPtCl(2)](-) and [(CN)(2)Py(2)PyzPdCl(2)](-), were measured in pyridine, DMF, and DMSO and show pi-pi* transitions, as well as unusually intense absorptions in the near-IR region (500-900 nm) of the spectrum.

The RNA replication machinery of HCV is a multi-subunit membrane-associated complex. NS5A has emerged as an active component of HCV replicase, possibly involved in regulation of viral replication and resistance to the antiviral effect of interferon. We report here substituted piperazinyl-N-(aryl)benzamides as potent inhibitors of HCV replication exerted via modulation of the dimerization of NS5A.

We report the evolutionary path from an open-chain series to conformationally constrained tetracyclic indole inhibitors of HCV NS5B-polymerase, where the C2 aromatic is tethered to the indole nitrogen. SAR studies led to the discovery of zwitterionic compounds endowed with good intrinsic enzyme affinity and cell-based potency, as well as superior DMPK profiles to their acyclic counterparts, and ultimately to the identification of a pre-clinical candidate with an excellent predicted human pharmacokinetic profile.

Tetrakis-2,3-[5,6-di-(2-pyridyl)pyrazino]porphyrazinatopalladium(II) [Py 8TPyzPzPd] ( 1) and the corresponding pentapalladated species [(PdCl 2) 4Py 8TPyzPzPd] ( 2), dissolved (c approximately 10 (-5)-10 (-6) M) in preacidified dimethylformamide ([HCl] approximately 10 (-4) M), behave as potent photosensitizing agents for the production of singlet oxygen, (1)O 2, with Phi Delta values of 0.89 +/- 0.04 and 0.78 +/- 0.05, respectively. The related octacation [(2-Mepy) 8TPyzPzPd] (8+) ( 3), examined under similar experimental conditions, exhibits lower Phi Delta values, that is, 0.29 +/- 0.02 (as an iodide salt) and 0.32 +/- 0.02 (as a chloride salt). In view of the very high values of Phi Delta, the photophysics of complexes 1 and 2 has been studied by means of pump and probe experiments using ns laser pulses at 532 nm as excitation source. Both complexes behave like reverse saturable absorbers at 440 nm because of triplet excited-state absorption. The lifetimes of the triplet excited states are 65 and 96 ns for the penta- and mononuclear species, respectively. Fluorescence quantum yields (Phi f) are approximately 0.1% for both 1 and 2. Such low Phi f values for the two complexes are consistent with the high efficiency of triplet excited-state formation and the measured high yields of (1)O 2. Time-dependent density-functional theory (TDDFT) calculations of the lowest singlet and triplet excited states of the mono- and pentapalladated species help to rationalize the photophysical behavior and the relevant activity of the complexes as photosensitizers for the (1)O 2 ( (1)Delta g) generation.

New palladium(II) complexes of the free-base tetrakis[2,3-(5,6-di-2-pyridylpyrazino)porphyrazine], [Py 8TPyzPzH 2], have been prepared and their physicochemical properties examined. The investigated compounds are the pentanuclear species [(PdCl 2) 4Py 8TPyzPzPd], the monopalladated complex [Py 8TPyzPzPd], and its corresponding octaiodide salt [(2-Mepy) 8TPyzPzPd](I) 8. All three Pd (II) complexes have a common central pyrazinoporphyrazine core and differ only at the periphery of the macrocycle, where the simple dipyridinopyrazine fragments present in [Py 8TPyzPzPd] bear four PdCl 2 units coordinated at the pyridine N atoms in the pentanuclear complex, [(PdCl 2) 4Py 8TPyzPzPd], or carry pyridine-N(CH 3) (+) moieties in the iodide of the octacation [(2-Mepy) 8TPyzPzPd] (8+). The structural features of the pentanuclear complex [(PdCl 2) 4Py 8TPyzPzPd], partly supported by X-ray data and solution (1)H NMR spectra of the [(CN) 2Py 2PyzPdCl 2] precursor, were elucidated through one- and two-dimensional (1)H NMR spectra in solution and density functional theory (DFT) calculations. Structural information on the monopalladated complex [Py 8TPyzPzPd] was also obtained from DFT calculations. It was found that in the complex [(PdCl 2) 4Py 8TPyzPzPd] the peripheral PdCl 2 units adopt a py-py coordination mode and the generated N 2PdCl 2 moieties are directed nearly perpendicular to the plane of the pyrazinoporphyrazine ring, strictly recalling the arrangement found for the palladated precursor [(CN) 2Py 2PyzPdCl 2]. NMR and DFT results consistently indicate that of the four structural isomers predictable for [(PdCl 2) 4Py 8TPyzPzPd], one having all four N 2PdCl 2 moieties pointing on the same side of the macrocyclic framework (i.e., isomer 4:0, plus the 3:1 and the 2:2-cis and 2:2-trans isomers), the 4:0 isomer ( C 4 v symmetry) is the predominant form present. According to cyclic voltammetry and spectroelectrochemical results in pyridine, dimethyl sulfoxide (DMSO), and dimethylformamide (DMF), the monopalladated complex [Py 8TPyzPzPd] undergoes four reversible or quasi-reversible one-electron ligand-centered reductions, similar to the behavior also observed for the pentanuclear complex [(PdCl 2) 4Py 8TPyzPzPd], which shows an additional reduction peak attributable to the presence of PdCl 2. Owing to the electron-withdrawing properties of the PdCl 2 units, the pentanuclear complex is easier to reduce than the mononuclear complex [Py 8TPyzPzPd], some related [Py 8TPyzPzM] complexes, and their porphyrin or porphyrazine analogues, so much so that the corresponding monoanion radical is generated at potentials close to 0.0 V vs SCE in DMSO or DMF. In turn, the monoanion of [(2-Mepy) 8TPyzPzPd](I) 8 is also extremely easy to generate electrochemically. Indeed, because of the eight positively charged N-CH 3 (+) groups in this complex the first reduction occurs at potentials close to +0.10 V in DMSO or DMF. The redox behavior of the mono- and pentapalladated complexes has been rationalized on the basis of a detailed DFT analysis of their ground-state electronic structure.

Allosteric inhibition of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase enzyme has recently emerged as a viable strategy toward blocking replication of viral RNA in cell-based systems. We report here 2 series of indole-N-acetamides, bearing physicochemically diverse carboxylic acid replacements, which show potent affinity for the NS5B enzyme with reduced potential for formation of glucuronide conjugates. Preliminary optimization of these series furnished compounds that are potent in the blockade of subgenomic HCV RNA replication in HUH-7 cells.

The redox properties of the phthalocyanine-like tetrakis(thiadiazole)porphyrazines, [TTDPzM] (M = MgII(H2O), ZnII, CuII, 2HI), were investigated by cyclic voltammetry, and their ground- and excited-state electronic properties were studied in detail by density functional theory (DFT) and time-dependent DFT (TDDFT) methods. Bulk and specific (axial ligation) solvent effects on the molecular and electronic structure were also taken into account. The title compounds show stepwise reversible ligand-centered one-electron reductions in the range 0 to -2.0 V vs SCE, with E1/2 values being systematically less negative than corresponding reduction potentials for the same processes of the phthalocyanine (Pc) analogues. No electroxidations were observed at positive potentials. The observed redox behavior is rationalized on the basis of the ground-state electronic structures which reveal that replacement of the benzo rings of the Pc macrocycle by electron-withdrawing thiadiazole rings induces a large stabilization of both the HOMO and LUMOs in the investigated macrocycles. An excellent correlation is found between the first one-electron reduction potentials and the gas-phase LUMO energies along the series. The same sequence in the first reduction potentials is theoretically reproduced in pyridine, even if the ZnII and MgII complexes are assumed to be in the axially ligated form, [TTDPzM(py)]. TDDFT calculations of the lowest excited states of the ZnII, MgII, and CuII complexes in pyridine provide an accurate description of their UV-visible spectra. The calculated optical spectra for the free-base macrocycle in chlorobenzene and pyridine confirm previous data in that the thiadiazoleporphyrazine [TTDPzH2] is mostly present in pyridine in its deprotonated form [TTDPz]2-. DFT results, in keeping with electrochemical data, indicate, however, that in pyridine it is the neutral species [TTDPzH2] being reduced instead of its deprotonated form [TTDPz]2-.

The multiphoton absorption properties of the tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazinato(monoacquo)-Mg(II) complex [Py(8)TPyzPzMg(H(2)O)] (1) are reported and interpreted. The nonlinear optical behavior of 1 and the characterization of the excited states important for the nonlinear absorption process were studied at the pump frequency of the second harmonic generation of a Nd:YAG laser in the nanosecond time regime. It was found that complex 1 shows a very good optical limiting performance at 532 nm, which derives from two processes: (a) a reverse-saturable absorption process, which involves a triplet excited state at low intensities, and (b) a two-photon absorption process at higher intensities, which is due to the formation of the radical monoanion of 1, [Py(8)TPyzPzMg(H2O)](.-), during the photoreduction of the triplet state. The participation of a monoanion in determining the overall nonlinear absorption behavior of 1 is found, for the first time, for a tetrapyrrolic system. One can deduce that the involvement of the monoanion derives from the electron-withdrawing effect of the dipyridinopyrazino fragments externally attached to the porphyrazine core which make the reduced form of 1 easily accessible. These results suggest a modification of tetrapyrrolic systems with new nonlinear absorption properties.

A novel ditetrapyrrolic, heteroleptic, and heterometallic (Mn-Cr) mu-hydroxo-bridged complex has been prepared, and its structural and general properties have been studied. The species mu-hydroxo(tetraphenylporphyrinatomanganese(III))(phthalocyaninato(azido)chromium(III)), [(TPP)Mn-O(H)-CrPc(N3)], isolated as a chloronaphthalene (ClNP) solvate, has been structurally characterized by single-crystal X-ray work. The two (TPP)Mn and CrPc(N3) fragments are held together by the bridging mu-hydroxo ion with long Mn-O [1.993(5) A] and Cr-O [1.976(5) A] bond distances and a Mn-O(H)-Cr angle of 163.7(3) degrees . The five-coordinate Mn center in the (TPP)Mn fragment is displaced from the TPP rigorously planar central N4 core by 0.128 A, and the environment is typical of a Mn(III) high-spin site. The six-coordinate Cr(III) in the CrPc(N3) moiety lies practically in the plane of the phthalocyanine macrocycle (displacement toward the azido group: 0.054 A). The average Mn-N(pyr) and Cr-N(pyr) bond distances are 2.011(6) and 1.982(6) A, respectively, and the Mn-Cr bond distance is 3.929(2) A. The porphyrin and phthalocyanine rings are in an almost eclipsed position [5.16(2) degrees ], and the mean planes of the two macrocycles form a dihedral angle of 5.79(4) degrees. Crystal data for [(TPP)Mn-O(H)-CrPc(N3)].2ClNP, C76H45CrMnN15O.2C10H7Cl: a = 16.645(3) A, b = 17.692(4) A, c = 25.828(5) A, alpha = 90 degrees , beta = 98.79(3) degrees , gamma = 90 degrees , space group P2(1)/c (No. 14), V = 7517(3) A(3), Z = 4, R1 = 0.086, and wR2 = 0.267. IR and UV-vis-near-IR spectral and room temperature magnetic susceptibility data of the [Mn-Cr] species are also presented.

Thieno[3,2-b]pyrroles are a novel class of allosteric inhibitors of HCV NS5B RNA-dependent RNA polymerase which show potent affinity for the NS5B enzyme. Introduction of a polar substituent in the position N1 led to a compound that efficiently blocks subgenomic HCV RNA replication in HUH-7 cells with an EC50 of 2.9 microM.

A new octacationic macrocycle, tetrakis-2,3-[5,6-di{2-(N-methyl)pyridiniumyl}pyrazino]porphyrazine, was obtained in its hydrated form as the water-soluble iodide salt. This compound, abbreviated as [(2-Mepy)(8)TPyzPzH(2)](I(8)).8H(2)O (2-Mepy = 2(N-methyl)pyridiniumyl moiety), was obtained by demetalation of the corresponding Mg(II) complex, [(2-Mepy)(8)TPyzPzMg(H(2)O)](I(8)).5H(2)O, which in turn was prepared from its corresponding neutral hydrated species tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazinato(monoaquo)magnesium(II), [Py(8)TPyzPzMg(H(2)O)].4H(2)O, by reaction with CH(3)I in N,N-dimethylformamide. The quaternization reactions by using CH(3)I or methyl p-toluenesulfonate were also conducted on the monomeric precursor 2,3-dicyano-5,6-di(2-pyridyl)-1,4-pyrazine, [(CN)(2)Py(2)Pyz], with formation of the monoquaternized ion [(CN)(2)Py(2-Mepy)Pyz](+) neutralized by iodide and p-toluenesulfonate anions. Single-crystal X-ray work allowed elucidation of the structure of the two salt-like species. The diquaternized ion [(CN)(2)(2-Mepy)(2)Pyz](2+) could also be obtained as a p-toluenesulfonate salt, but attempts at direct macrocyclization of this dicationic species were unsuccessful. The iodide salt [(2-Mepy)(8)TPyzPzH(2)](I(8)).8H(2)O is water-soluble, with different solubilities depending on the range of pH explored. It was established that the macrocycle [(2-Mepy)(8)TPyzPzH(2)](8+) undergoes facile deprotonation and behaves as a strong acid. Aggregation phenomena are observed for both the octacation [(2-Mepy)(8)TPyzPzH(2)](8+) and its corresponding centrally deprotonated species [(2-Mepy)(8)TPyzPz](6+). Nevertheless, both cationic moieties exist in their monomeric form under specific experimental conditions. UV-visible monitored titrations with NaOH provide information about the type of protonation/deprotonation equilibria which are complicated by the occurrence of aggregation phenomena.

Metal derivatives of the octacationic tetrakis-2,3-[5,6-di{2-(N-methyl)pyridiniumyl}pyrazino]porphyrazine macrocycle [(2-Mepy)(8)TPyzPzH(2)](8+) (2-Mepy = 2-(N-methyl)pyridiniumyl ring) isolated as water-soluble hydrated iodide salts of the general formula [(2-Mepy)(8)TPyzPzM](I(8)).xH(2)O, (M = Mg(II)(H(2)O), Co(II), Cu(II), Zn(II); x = 2-5) were prepared from the corresponding neutral complexes [Py(8)TPyzPzM].xH(2)O previously reported. Reaction of these complexes with CH(3)I in N,N-dimethylformamide under mild conditions led to full quaternization of all eight pyridine N atoms and formation of the octacations [(2-Mepy)(8)TPyzPzM](8+). Clathrated water molecules could be eliminated from the species [(2-Mepy)(8)TPyzPzM](I(8)).xH(2)O by mild heating ( Co(I) process, but the site of electron transfer is reversed and the final product upon a further one-electron reduction is formulated as a Co(II) dianion as opposed to a Co(I) pi-anion radical. This sequence is similar to what was earlier reported for reduction of the same compound in pyridine. Reversible one-electron oxidations are also observed for the unmethylated species [Py(8)TPyzPzM].xH(2)O where M = Co(II) and Mn(II) in DMSO. Remarkably, the octacationic macrocycles [(2-Mepy)(8)TPyzPzM](I(8)).xH(2)O, (M = Mg(II)(H(2)O), Co(II), Cu(II), and Zn(II); x = 2-5) are more easily reduced at any step of the reduction than the corresponding unquaternized species with the same metal ion. This indicates a higher tendency to stepwise electron uptake after the quaternization process, which enhances the charge redistribution capability within the species formed by the electroreduction.

Monometallic derivatives of tetrakis(1,2,5-thiadiazole)porphyrazine, [TTDPzH2], with main group tervalent metal ions having the formulae [TTDPzMX] (TTDPz = tetrakis(1,2,5-thiadiazole)porphyrazinato dianion; M = Al(III), X = Cl-, Br-, OH-; M = Ga(III), X = Cl-, OH-; M = In(III), X = AcO-) were prepared and investigated by single-crystal X-ray analysis and IR and UV-vis spectroscopy as well as cyclic voltammetry and spectroelectrochemistry. The complexes [TTDPzMX] (M = Al(III), X = Cl-, Br-; M = Ga(III), X = Cl-) were obtained by direct autocyclotetramerization of the precursor 3,4-dicyano-1,2,5-thiadiazole in hot quinoline in the presence of MX3 salts (M = Al(III), Ga(III); X = Cl-, Br-) and were hydrolized to form the corresponding hydroxide derivatives, [TTDPzMOH]. The In(III) complex, [TTDPzIn(OAc)], was obtained from the free-base macrocycle [TTDPzH2] with In(OH)(OAc)2 in CH3COOH. A single-crystal X-ray study was made at 173 K on the two isostructural species [TTDPzMCl] (M = Al(III), Ga(III)), which have space group P, with a = 12.470(14), b = 12.464(13), and c = 13.947(12) angstroms, alpha = 70.72(3), beta = 79.76(3), and gamma = 90.06(3) degrees, V = 2009.3(3) angstroms3, and Z = 4 for [TTDPzAlCl] and a = 12.429(3), b = 12.430(3), and c = 13.851(3) angstroms, alpha = 70.663(6), beta = 79.788(8), and gamma = 89.991(9) degrees, V = 1983.3(7) angstroms3, and Z = 4 for [TTDPzGaCl]. Square pyramidal coordination exists about the M(III) centers, with Cl- occupying the apical position (Al-Cl = 2.171(5) and Ga-Cl = 2.193(1) angstroms). Al(III) and Ga(III) are located at distances of 0.416(6) and 0.444(2) angstroms from the center of the N4 system. The molecular packing consists of stacked double layers with internal and external average interlayer distances of 3.2 and 3.3 angstroms, respectively. IR spectra show nu(Al-Cl) at 345 cm(-1) for [TTDPzAlCl], nu(Al-Br) at 330 cm(-1) for [TTDPzAlBr], and nu(Ga-Cl) at 382 cm(-1) for [TTDPzGaCl]. The UV-vis spectra in weakly basic (pyridine, DMF, DMSO) and acidic solvents (CF3COOH, H2SO4) show the typical intense pi --> pi transition bands in the Soret (300-400 nm) and Q-band regions (640-660 nm), the bands evidencing some dependence on the nature of the solvent, particularly in acidic solutions. Cyclic voltammetry, differential pulse voltammetry, and thin-layer spectroelectrochemical measurements in pyridine and dimethylformamide of the species [TTDPzMX] indicate reversible first and second one-electron reductions, whereas additional ill-defined reductions are observed at more negative potentials. The examined species are much easier to reduce than their phthalocyanine or porphyrin analogues as a result of the remarkable electron-attracting properties of the TTDPz macrocycle which contains annulated strongly electron-deficient thiadiazole rings.

A series of metal complexes of tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazine, [Py(8)TPyzPzH(2)], having the general formula [Py(8)TPyzPzM].xH(2)O (M = Mg(II)(H(2)O), Mn(II), Co(II), Cu(II), Zn(II); x = 3-8) were synthesized by reaction of the free-base macrocycle with the appropriate metal acetate in pyridine or dimethyl sulfoxide under mild conditions. Clathrated water and retained pyridine molecules for the Mn(II) and Co(II) species are easily eliminated by heating under vacuum, the water molecules being recovered by exposure of the unsolvated macrocycles to air. Magnetic susceptibility measurements and EPR spectra of the materials in the solid state provide basic information on the spin state of the Cu(II), Co(II), and Mn(II) species. Colloidal solutions caused by molecular aggregation are formed in nondonor solvents (CH(2)Cl(2), CHCl(3)), a moderately basic solvent (pyridine), and an acidic solvent (CH(3)COOH), with the extent of aggregation depending on the specific solvent and the central metal ion. UV-vis spectral monitoring of the solutions after preparation indicates that disaggregation systematically occurs as a function of time leading ultimately to the formation of clear solutions containing the monomeric form of the porphyrazine. Cyclic voltammetry and thin-layer spectroelectrochemistry show that each compound with an electroinactive metal ion undergoes four reversible one-electron reductions, leading to formation of the negatively charged species [Py(8)TPyzPzM](n-) (n = 1 - 4). The stepwise uptake of four electrons is consistent with a ring-centered reduction, but in the case of the cobalt complex a metal-centered (Co(II) --> Co(I)) reduction occurs in the first process and only three additional reductions are observed. No oxidations are observed in pyridine or CH(2)Cl(2) containing 0.1 M tetrabuthylammonium perchlorate (TBAP). The nonlinear optical properties (NLO) of the species [Py(8)TPyzPzM] (M = 2H(I), Cu(II), Zn(II), Mg(II)(H(2)O)) have also been examined with nanosecond pulses at 532 nm in dimethyl sulfoxide solution. Reverse saturable absorption is shown by all of the [Py(8)TPyzPzM] species, which exhibit distinct behavior depending on the nature of M and extent of aggregation.

A new pyrazinoporphyrazine macrocycle carrying externally appended pyridine rings, tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazine (hydrated), [Py(8)TPyzPzH(2)].2H(2)O, was prepared in high yield by direct cyclotetramerization of the precursor, 2,3-dicyano-5,6-di(2-pyridyl)-1,4-pyrazine, [(CN)(2)Py(2)Pyz], in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The single-crystal X-ray structure of [(CN)(2)Py(2)Pyz] shows a noncoplanar positioning of the pyrazine and pyridine rings in the two slightly different independent molecular units present in the crystal. UV-vis spectra of [Py(8)TPyzPzH(2)] were measured in two nondonor solvents (CHCl(3), CH(2)Cl(2)), a slightly basic solvent (pyridine), and an acidic solvent (CH(3)COOH). In all cases, the spectral changes are consistent with the occurrence of molecular aggregation and colloidal dispersions which break up with time to give clear solutions containing exclusively the monomeric form of the macrocycle, either neutral [Py(8)TPyzPzH(2)] (in CHCl(3), CH(2)Cl(2), and CH(3)COOH) or dianionic [Py(8)TPyzPz](2)(-) (in pyridine). A spectrally monitored titration of [Py(8)TPyzPzH(2)] in CH(2)Cl(2) with TBA(OH) shows the loss of two protons from the macrocyclic core and quantitative conversion of [Py(8)TPyzPzH(2)] to [Py(8)TPyzPz](2)(-). Cyclic voltammetry and thin-layer spectroelectrochemical measurements show that [Py(8)TPyzPzH(2)] is present in CH(2)Cl(2) while [Py(8)TPyzPz](2)(-) is present in pyridine, but both forms of the compound exhibit identical electrochemical behavior, consistent with a conversion of the dianion to the neutral porphyrazine in pyridine prior to electroreduction via four reversible one-electron transfer steps. No oxidations of the macrocycle are observed in either solvent containing 0.1 M tetrabuthylammonium perchlorate (TBAP). A comparison of the electrochemical behavior for [Py(8)TPyzPzH(2)] with what is reported for related phthalocyanine and porphyrazine analogues highlights the remarkable electron-accepting properties of the presently investigated free-base macrocycle.

Following a previous report on the synthesis and physicochemical characterization of a novel class of porphyrazines carrying peripherally annulated seven-membered rings, i.e., tetrakis-2,3-(5,7-diphenyl-1,4-diazepino)porphyrazine [Ph(8)DzPzH(2)].4H(2)O and its metal derivatives [Ph(8)DzPzM].xH(2)O (x = 2-7, M = Mg(II)(H(2)O), Cu(II), and Zn(II)), a new more convenient procedure is reported here, allowing the preparation in high yields of the Li(I) and Na(I) derivatives of formulas [Ph(8)DzPzLi(2)].5H(2)O and [Ph(8)DzPzNa(2)].6H(2)O, which can be directly converted into other metal derivatives under mild conditions (room temperature) and in good yields. The series studied has been extended to include the Mn(II) and Co(II) complexes also reported here for the first time. Physicochemical characterization of the new "diazepinoporphyrazines" was based on fast atom bombardment (FAB) mass spectrometry and X-ray powder patterns, infrared (IR), electron paramagnetic resonance (EPR), and room-temperature magnetic susceptibility measurements. A detailed discussion of the UV-vis spectra emphasizes the role played by the external diazepine rings in electron delocalization through their tautomeric or protonated forms present in neutral, basic, and acidic media. The nonlinear optical effect of optical limiting for the different species [M = 2H, Mg(II)(H(2)O), Mn(II), Co(II), Cu(II), and Zn(II)] has also been measured. It has been observed that the extent of the optical limiting depends on the specific M center. The observed nonlinear optical features are analyzed and discussed in terms of the electronic and magnetic properties exhibited by some of the metal ions and taking into account the model of the excited-state absorption in which the nature of M determines the kinetics of formation of the highly absorbing state of the specific complex examined. As evidenced by the detailed electrochemical and spectroelectrochemical study carried out on this new class of macrocycles, one of the most important aspects is the facilitated electron delocalization for the oxidized and reduced species allowed by a 1H-6Htautomerism taking place on the peripheral diazepine rings.

Co-cyclization of 1,2,5-thiadiazole-3,4-dicarbonitrile and 3,6-diamyloxyphthalodinitrile in the presence of magnesium or lithium amylate in amyl alcohol leads to mixtures containing the Mg derivatives of the symmetrical species tetrakis(1,2,5-thiadiazolo)porphyrazine, (S(4))PzH(2), and tetrakis(1,4-diamyloxybenzo)porphyrazine, (A(4))PzH(2), and the low-symmetry macrocycles bearing peripheral 1,2,5-thiadiazole and 1,4-diamyloxybenzene rings in the ratio 1:3, 2:2 (cis and trans), and 3:1, that is, (SA(3))PzH(2), (S(2)A(2))PzH(2), (SASA)PzH(2), and (S(3)A)PzH(2), respectively. The basic Mg materials were converted to the corresponding free-base macrocycles by treatment with CF(3)COOH. The species were separated from the mixtures by chromatography, either as Mg complexes or demetalated materials. With results on (S(4))PzH(2) and (SA(3))PzH(2) in hand, including crystallographic work on the latter, a general chemical physical investigation has been carried out of all the symmetrical and unsymmetrical free-base macrocycles. The structures of the species (S(2)A(2))PzH(2) and (A(4))PzH(2). were elucidated by single-crystal X-ray crystallography. The effect of the progressive variation of the macrocyclic structure along the series, from the symmetrical (S(4))PzH(2) to its symmetrical partner (A(4))PzH(2) via the low-symmetry 3:1, 2:2 (cis and trans), and 1:3 macrocycles, was studied by IR, (1)H NMR, and UV/Vis linear and nonlinear (optical limiting) measurements. The results are interpreted on the basis of intra- and intermolecular interactions between the electron-deficient 1,2,5-thiadiazole and the electron-donating 1,4-diamyloxybenzene moieties.

Recrystallization of the previously reported monosolvated bis(phthalocyaninato)niobium(IV), [Pc2Nb].CINP (CINP = 1-chloronaphthalene), has allowed isolation of a single crystal of a new solvated form, i.e. [Pc2Nb]. 3.5CINP, whose structure has been elucidated by X-ray work: space group P2(1)/n (No. 14); a = 16.765(3), b = 23.800(4), c = 19.421(4) A; alpha = gamma = 90 degrees, beta = 92.51(2) degrees; Z = 4. The sandwiched material is a "stapled" molecule, characterized by the presence of two intramolecular interligand C-C sigma bonds and highly strained phthalocyanine units, as formerly observed by crystallographic work for its Ti(IV) analogue, [Pc2Ti], and the +1 corresponding fragment, [Pc2Nb]+, present in the species [Pc2Nb](l3)(l2)0.5.3.5CINP. [Pc2Nb] appears to be reluctant to undergo further oxidation above the +1 oxidation state. Detailed theoretical studies by DFT and TDDFT methods have been developed on [Pc2Nb] and [Pc2Nb]+, also extended for comparison to the Ti(IV) complex [Pc2Ti], and an adequate picture of the ground-state electronic structure of these species has been achieved. Moreover, the excitation energies and oscillator strengths calculated for the closed-shell systems, [Pc2Ti] and [Pc2Nb]+, provide a satisfactory interpretation of their characteristic visible optical spectra and help to rationalize the similar features observed in the visible spectrum of the open-shell "stapled" complex, [Pc2Nb]. Thin solid films (100-250 nm) of [Pc2Nb] deposited on ITO (indium-doped tin oxide) show a reversible redox process in neutral or acidic aqueous electrolytes. The electrochemical and electrochromic properties of the sandwiched complex, combined with impedance and UV/visible spectral measurements, are presented and discussed. The achieved electrochemical information, while substantially in keeping with the observed chemical redox behavior and theoretical predictions, qualifies [Pc2Nb] as an "optically passive" electrode and a promising material for its use in electrochromic devices.

The reaction of mu-nitrido[((tetraphenylporphyrinato)manganese)(phthalocyaninatoiron)], [(TPP)Mn-N-FePc], with I(2) in THF develops with the formation of two different species, i.e., [(THF)(TPP)Mn-N-FePc(H(2)O)](I(5)).2THF (I) and [(TPP)Mn(IV)-N-Fe(III)Pc](I(3)) (II). On the basis of single-crystal X-ray work and Mössbauer, EPR, Raman, and magnetic susceptibility data, I, found to be isostructural with the corresponding Fe-Fe complex, is shown to contain a low-spin triatomic Mn(IV)=N=Fe(IV) system (metal-centered oxidation). Data at hand for II (Mössbauer, EPR, Raman) show, instead, that oxidation takes place at one of the two macrocycles, very likely TPP (ligand-centered oxidation). The same cationic fragment present in I, and containing the Mn(IV)=N=Fe(IV) bond system, is also obtained when (TPP)Mn-N-FePc is allowed to react in THF with (phen)SbCl(6) (molar ratio 1:1). There are indications that the use of (phen)SbCl(6) in excess (2:1 molar ratio), in benzene, probably determines further oxidation with the formation of a species showing the combined presence of the Mn(IV)-Fe(IV) couple and of a pi-cation radical.

Digital Pacinian Hyperplasia is a non tumoral, very rare lesion. To date, only 31 cases have been reported, occasionally named Digital Pacinian Neuroma. Digital pain is usually associated to. Local trauma is reported in about half of the cases. We report a new case occurred in a 62 year-old male, associated with inflammatory and foreign body reaction. No recurrence was observed 6 months after surgical excision. Differential diagnosis and controversies about this lesion are discussed.